The popularity of Sildenafil initially sparked a period of growth for the drug industry, nevertheless recent changes present a complicated outlook for those considering a stake. Lower-cost alternatives are eroding earnings, and ongoing patent challenges add additional risk to the situation. While some companies could still benefit from complemen… Read More